Pro Medicus Limited (AU:PME) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Pro Medicus Limited has announced the issuance of 67,256 new performance rights on August 26, 2024, as part of their employee incentive scheme. These rights are unquoted, meaning they will not be traded on the ASX, reinforcing the company’s commitment to its employees through performance-based incentives.
For further insights into AU:PME stock, check out TipRanks’ Stock Analysis page.
